Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow

Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow

Anthony Lee

Mon, February 16, 2026 at 12:05 PM GMT+9 2 min read

In this article:

MED

-0.37%

Wellness company Medifast (NYSE:MED) will be reporting results this Tuesday after the bell. Here’s what to expect.

Medifast met analysts’ revenue expectations last quarter, reporting revenues of $89.41 million, down 36.2% year on year. It was a very strong quarter for the company, with EPS guidance for next quarter exceeding analysts’ expectations and a beat of analysts’ EPS estimates.

Is Medifast a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Medifast’s revenue to decline 40% year on year to $71.4 million, a further deceleration from the 37.7% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.82 per share.

Medifast Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Medifast has missed Wall Street’s revenue estimates three times over the last two years.

Looking at Medifast’s peers in the personal care segment, some have already reported their Q4 results, giving us a hint as to what we can expect. e.l.f. Beauty delivered year-on-year revenue growth of 37.8%, beating analysts’ expectations by 6.4%, and Estée Lauder reported revenues up 5.6%, in line with consensus estimates. e.l.f. Beauty traded down 9.2% following the results while Estée Lauder was also down 16.8%.

Read our full analysis of e.l.f. Beauty’s results here and Estée Lauder’s results here.

There has been positive sentiment among investors in the personal care segment, with share prices up 3.7% on average over the last month. Medifast is down 7.6% during the same time and is heading into earnings with an average analyst price target of $15 (compared to the current share price of $10.78).

Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Terms and Privacy Policy

Privacy Dashboard

More Info